Dr Susan Byrne is a Senior Lecturer in FutureNeuro/department of paediatrics and child health in RCSI, and consultant paediatric neurologist in CHI at Crumlin. Susan graduated from medical school in Trinity College in 2005. Between 2009 and 2012 she completed her PhD in genetic epidemiology where she learned about the value of patient registries in furthering our understanding of disease and working towards a cure. Prior to her move back to Ireland in 2021, Susan worked as a Paediatric Neurology consultant in the Evelina London Children’s hospital. During her time there, she specialized in neuroinflammatory disorders of childhood and paediatric stroke, as well as general paediatric neurology including neurogenetic conditions. During the Covid-19 pandemic Susan was involved in describing the neurological features of PIMS-TS. Susan works as part of the CORAL study (The Impact of CORona Virus Pandemic on InfAnts Born During Lockdown) and leads the neurodevelopmental arm. The CORAL team were the first to report deficits in communication in infants born during the COVID-19 pandemic. Since completing her PhD, Susan’s main area of interest is in genotype/phenotype correlation in the neurogenetic disorders of childhood and the capabilities of neurogenetic diagnostic testing. Together with her collaborators in CHI and FutureNeuro, she has established the CINDI registry for children with neurogenetic conditions, and the EpiFUN study which seeks to further genetic diagnostic rates in children with neurogenetic disorders.